Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.
MedComms Networking - 05 July 2016
I'm looking forward to a couple of good events this week. Our next Brunch Meeting tomorrow in Oxford is about editorial type matters with Rachael Lammey and Pippa Smart of The European Association of Science Editors (EASE), when we'll be filming another set of webcasts for everyone. Then, on Thursday we're at Alderley Park, hosted by AstraZeneca for Understanding the role of real-world evidence (RWE) in a medical publication plan, which looks like being 'a corker'! I look forward to seeing many of you there.
Meanwhile the hot topic this past week, at least in some circles, was the news that on 30 June the UK's Association of the British Pharmaceutical Industry (ABPI) published, for the first time, details of payments or benefits in kind made to doctors, nurses and pharmacists, as well as other health professionals and organisations in the UK, on a publicly accessible database called Disclosure UK.
Here's some useful reading for your next tea-and-cakes break...
Pharmaceutical industry spends 340.3 million GBP on working in partnership with leading UK health experts and organisations to improve patient care is the press release from The ABPI.
Pharma spent 340 million GBP on healthcare partnerships in 2015 from PharmaTimes reported that "An estimated 70 percent of individual healthcare professionals are currently giving their consent for this information to be disclosed on a named basis."
Which, I guess, doesn't sound too bad but as noted in UK healthcare professionals received 340.3 million GBP in benefits from pharma industry in 2015 discloses ABPI from Pharmafocus, the disclosure is not all inclusive and will be an evolving database and "typically those who are receiving more have chosen not to disclose."
Oh - that's maybe not so good!
The papers picked up the news, and headlines included these from The Telegraph;
NHS staff shun 'transparency register' listing payments from drugs firms
Individual NHS doctors receiving 100,000 GBP per year from drugs firms
Drugs firms should refuse to pay doctors who won't declare earnings, says NHS.
Ben Goldacre jumped in straight away and tweeted "Pharma payments to doctors etc now up on ABPI database, we are researching the gaps / missing payments, more soon."
Meanwhile last week the CMS released US data for 2015 as reported by Policy and Medicine in Open Payments 2015 Data Released.
It's a brave new - transparent - world, in more ways than one.
However, despite the challenges and the current brouhaha surrounding us generally at the moment, we know MedComms remains a strong and vibrant business - and we need more talented individuals to join us! Over at FirstMedCommsJob.com we're doing what we can to attract them. This week we've added details of several relevant articles published in the latest issue of Medical Writing from EMWA and a new Profile from Georgina Ryan, Associate Medical Editor, Darwin Healthcare Communications. Drop me a line if you'd like to contribute and please help spread the word about our next Careers event in Manchester on 14 September. Many thanks!
Enjoy your week, everyone.
Managing Director, NetworkPharma Ltd
Follow me on Twitter @NetworkPharma
Join 3,000 international colleagues in the MedComms Networking Linkedin Group
The information at www.MedCommsNetworking.com is always bang up-to-date!